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Cellular/Molecular
Dopamine Transporter Endocytic Trafficking in Striatal
Dopaminergic Neurons: Differential Dependence on
Dynamin and the Actin Cytoskeleton
Luke R. Gabriel,2 Sijia Wu,2 Patrick Kearney,1 Karl D. Bellve´,3 Clive Standley,3 Kevin E. Fogarty,3 and Haley E. Melikian1
Brudnick Neuropsychiatric Research Institute, 1Department of Psychiatry, 2Neuroscience Graduate Program, Graduate School of Biomedical Sciences, and
3Program in Molecular Medicine, Biomedical Imaging Group, University of Massachusetts Medical School, Worcester, Massachusetts 01655
Dopaminergic signaling profoundly impacts rewarding behaviors, movement, and executive function. The presynaptic dopamine (DA)
transporter (DAT) recaptures released DA, thereby limiting synaptic DA availability and maintaining dopaminergic tone. DAT consti-
tutively internalizes and PKC activation rapidly accelerates DAT endocytosis, resulting in DAT surface loss. Longstanding evidence
supports PKC-stimulated DAT trafficking in heterologous expression studies. However, PKC-stimulated DAT internalization is not
readily observed in cultured dopaminergic neurons. Moreover, conflicting reports implicate both classic and nonclassic endocytic
mechanisms mediating DAT trafficking. Prior DAT trafficking studies relied primarily upon chronic gene disruption and dominant-
negative protein expression, or were performed in cell lines and cultured neurons, yielding results difficult to translate to adult dopami-
nergic neurons. Here, we use newly described dynamin inhibitors to test whether constitutive and PKC-stimulated DAT internalization
aredynamin-dependent in adult dopaminergic neurons.Exvivobiotinylation studies inmouse striatal slices demonstrate that acutePKC
activationdrivesnativeDATsurface loss, and that surfaceDATsurprisinglypartitionsbetweenendocytic-willing andendocytic-resistant
populations. Acute dynamin inhibition reveals that constitutive DAT internalization is dynamin-independent, whereas PKC-stimulated
DAT internalization is dynamin-dependent. Moreover, total internal reflection fluorescence microscopy experiments demonstrate that
constitutive DAT internalization occurs equivalently from lipid raft and nonraft microdomains, whereas PKC-stimulated DAT internal-
izationarises exclusively from lipid rafts. Finally,DATendocytic recycling relies onadynamin-dependentmechanismthat acts in concert
with the actin cytoskeleton. These studies are the first comprehensive investigationofnativeDAT trafficking in ex vivo adult neurons, and
reveal that DAT surface dynamics are governed by complex multimodal mechanisms.
Introduction
Dopamine (DA) neurotransmission is obligatory for movement,
and the dopaminergic circuitry is intimately coupled to reward-
ing behavior (Hyman et al., 2006) and cognitive function (Lyon
et al., 2011). DA’s extracellular half-life and neuronal DAergic
tone are determined byDA transporter (DAT)-mediated presyn-
aptic reuptake. DAT is an SLC6 solute carrier robustly expressed
in substantia nigra and ventral tegmental area dopaminergic neu-
rons (Amara et al., 1998; Kristensen et al., 2011; Bro¨er and
Gether, 2012). Multiple therapeutic and addictive drugs potently
inhibit DAT, including methylphenidate (ritalin), NDRI antide-
pressants, amphetamine (AMPH), and cocaine (Gether et al.,
2006). Investigations using a cocaine-insensitive DAT knock-in
mouse demonstrated that cocaine reward absolutely requires
DAT inhibition (Thomsen et al., 2009; Tilley et al., 2009). In
addition to its role as a pharmacological target several DAT cod-
ing variants are reported in attention-deficit hyperactivity disor-
der (ADHD; Mazei-Robison and Blakely, 2005; Mazei-Robison
et al., 2008; Bowton et al., 2010; Sakrikar et al., 2012) and autism
spectrum disorder (Hamilton et al., 2013) patients. Additionally,
DATdysfunction downstreamofCaMKII anomalies occurs in an
Angelman syndrome mouse model (Steinkellner et al., 2012).
Given DAT’s critical role in normal neurotransmission, as a
drug target and in dopaminergic pathologies, cellular mecha-
nisms modulating DAT availability are likely to significantly im-
pact behavior and overall homeostasis. Longstanding evidence
supports that DAT surface presentation is highly plastic and is
subject to regulated endocytic trafficking (Torres et al., 2003;
Melikian, 2004). DAT constitutively internalizes and recycles,
and protein kinase C activation rapidly accelerates DAT internal-
ization rates, resulting in acute DAT surface loss. Moreover a
DAT coding variant in an ADHD patient encodes a carboxy-
terminal point mutation that results in anomalously rapid DAT
endocytosis (Sakrikar et al., 2012), suggesting that regulatedDAT
trafficking may profoundly influence executive function.
Significant effort has been directed at deciphering the mech-
anisms that dictate DAT endocytic trafficking. Several studies
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implicate classic clathrin-dependent endocytic machinery (Dan-
iels and Amara, 1999; Sorkina et al., 2005), whereas other studies
suggest that clathrin-independentmechanisms facilitate DAT in-
ternalization (Holton et al., 2005; Boudanova et al., 2008b; Cre-
mona et al., 2011). Moreover, several reports indicate that DAT
targets to degradative pathways following internalization (Dan-
iels and Amara, 1999; Miranda et al., 2005; Eriksen et al., 2010),
whereas other reports suggest that DAT traffics via the endocytic-
recycling pathway (Loder and Melikian, 2003; Boudanova et al.,
2008b; Furman et al., 2009). DAT internalization studies have
been performed in various neuronal, neuroendocrine, and non-
neuronal cell lines, as well as in rodent synaptosomes and pri-
mary ventral midbrain cultures, raising concerns regarding
which studies reflect native DAT endocytic mechanisms. More-
over, many studies chronically disrupt classic clathrin- and
dynamin-dependent endocytic trafficking, which could poten-
tially have deleterious effects throughout the biosynthetic path-
way. Here, we capitalize on newly developed pharmacological
tools to test whether constitutive and PKC-regulated DAT inter-
nalization are dynamin-dependent ex vivo in adult mouse stria-
tum. Our results suggest that DAT internalization and recycling
are differentially dependent upon dynamin and the actin cyto-
skeleton. Moreover, the endocytic capacity of surface DAT func-
tionally partitions into distinct populations that are membrane
raft independent.
Materials andMethods
Materials. pTagRFP-T-C1 vector was a generous gift fromDr Silvia Cor-
vera (University of Massachusetts Medical School, Worcester, Massa-
chusetts) and hDAT cDNA was cloned into pTagRFP-T-C1 in frame at
the HindIII/XbaI sites. Rat anti-DAT (MAB369) and mouse anti-
tyrosine hydroxylase (TH) antibodies were fromMillipore. Mouse anti-
transferrin receptor (TfR) antibody (H68.4), Tf-Alexa594 and cholera
toxin subunit B-Alexa488 were from Invitrogen. Mouse anti-actin anti-
bodies andHRP-conjugated secondary antibodies were from Santa Cruz
Biotechnology. Dynasore, dynoles, and phorbol 12-myristate 13-acetate
(PMA) were from Tocris Bioscience. Sulfo-NHS-SS-biotin and strepta-
vidin agarose were from Pierce Biotechnology. Dihydroxyphenylethyl-
amine, 3, 4-[Ring-2, 5, 6- 3H]dopamine and L-[ 3H]alanine were from
PerkinElmer. Monensin, cytochalasin D (CytoD) and reagents used for
ACSF were from Sigma-Aldrich. All other reagents were from Fisher
Scientific or Sigma-Aldrich and were of highest quality possible.
Cell culture.Thehumanneuroblastoma cell line SK-N-MCweremain-
tained in MEM (Sigma-Aldrich, no. M2279) supplemented with 10%
fetal bovine serum (Invitrogen), 2 mM L-glutamine and 100 Us/ml peni-
cillin/streptomycin at 37°C, 5% CO2. Pooled, stable SK-N-MC cell lines
expressing either hDAT or a TagRFP-T-hDAT fusion protein (Tag-RFP-
T-DAT) were generated by transfecting 1 106 cells/well in 6-well cul-
ture plates with 3 g plasmid DNA using Lipofectamine 2000, at lipid:
DNA ratio of 2:1 (w/w). Stably transformed cells were selected with 0.4
mg/ml geneticin (G418, Invitrogen) and resistant cells were pooled and
maintained under selective pressure with 0.16 mg/ml G418. PC12 cells
stably expressing hDAT were cultured as previously described (Loder
andMelikian, 2003) at 37°C, 10%CO2 inDMEMsupplementedwith 5%
bovine calf serum, 5% horse serum, 2 mM L-glutamine, 100 Us/ml peni-
cillin/streptomycin, 0.2 mg/ml G418.
Uptake assays.DAT-PC12 cells were seeded onto poly-D-lysine-coated
24-well plates at a density of 2 105/well 24 h before performing assays.
Cells were rinsed twice with Krebs-Ringer-HEPES (KRH) buffer (120
mM NaCl, 4.7 mM KCl, 2.2 mM CaCl2, 1.2 mM MgSO4, 1.2 mM KH2PO4,
0.18% glucose, and 10 mM HEPES, pH 7.4) and incubated in KRH/
0.18%glucose, 37°C for indicated times with the indicated drugs. For DA
transport, assays were initiated by adding 1 M [3H]DA in KRH supple-
mented with 105 M each pargyline and ascorbic acid. For Na-
dependent alanine transport, assays were initiated by adding 500 M
L-[3H]alanine. Assays proceeded for 10 min, 37°C, and were terminated
by rapidly washing cells with ice-cold KRH buffer. Cells were solubilized
in scintillation fluid, and accumulated radioactivity was determined by
liquid scintillation counting in a Wallac MicroBeta scintillation plate
counter. Nonspecific DA uptake was defined in the presence of 10 M
GBR12909 and all samples included 100 nM desipramine to block uptake
contribution by endogenously expressed norepinephrine transporters.
Nonspecific alanine uptake was defined in parallel in Na-free KRH
buffer prepared with 120 mM choline chloride. Data were analyzed using
GraphPad Prism software.
Cell surface biotinylation. Cells were seeded onto 6-well plates 24 h
before performing assays at densities of 1.6 106/well (DAT-SK-N-MC)
or 1.5 106/well (DAT-PC12. DAT-PC12 cells were seeded on poly-D-
lysine-coated plates. Cells were treated with the indicated drugs for the
indicated times and surface proteins were covalently labeled with sulfo
NHS-SS-biotin as previously described (Loder andMelikian, 2003; Hol-
ton et al., 2005). Briefly, cells were washed and rapidly chilled in ice-cold
PBS, pH 7.4, supplemented with 1.0 mMMgCl2, 0.1 mM CaCl2 (PBS
2),
and incubated with 1.0 mg/ml sulfo-NHS-SS-biotin in ice-cold PBS2
twice for 15 min at 4°C. Residual reactive biotin was quenched with two
incubations in PBS2/100 mM glycine, 15 min, 4°C. Cells were washed
three times in ice-cold PBS2, were lysed in RIPA buffer containing
protease inhibitors and protein concentrations were determined using
the BCA protein assay (Pierce). Biotinylated proteins were isolated by
batch streptavidin chromatography (overnight, 4°C) and bound proteins
were eluted in SDS-PAGE sample buffer. Total lysate sampleswere stored
in SDS-PAGE sample buffer, 20°C until analysis. Samples were re-
solved by SDS-PAGE and specific proteins were detected by immuno-
blotting with the indicated antibodies. Immunoreactive bands were
detected with SuperSignalWest Dura (Pierce) and were captured using a
VersaDoc Imaging station (Biorad). Nonsaturating bands were quanti-
fied using Quantity One software (Biorad).
Striatal slice biotinylation.All animals were handled in accordancewith
University of Massachusetts Medical School IACUC protocol A1506
(H.E.M.). P21–P38 male C57/B6 mice were killed by cervical dislocation
and decapitated. The brains were removed and immediately chilled in
sucrose-supplemented artificial CSF (SACSF; 2.5 mM KCl, 1.2 mM
NaH2PO4, 1.2 mM MgCl2, 2.4 mM CaCl2, 26 mM NaHCO3, 11 mM glu-
cose, and 250 mM sucrose) saturated with 95%O2/5%CO2. Brains were
mounted on a vibratome 1500 sectioning system and 300 m coronal
sections were made. Sections containing striatum were recovered in
ACSF (125 mMNaCl, 2.5 mM KCl, 1.2 mMNaH2PO4, 1.2 mMMgCl2, 2.4
mM CaCl2, 26 mM NaHCO3, and 11 mM glucose), 31°C, 40 min with
95%O2/5%CO2, then were immediately used for trafficking studies.
Slices were treated with the indicated drugs for the indicated times with
95%O2/5%CO2. Surface proteins were covalently labeledwith 1.0mg/ml
sulfo-NHS-SS-biotin in ice-cold ACSF, 45 min, 4°C, with bubbling
95%O2/5%CO2. Following biotinylation, slices were washed twice in
ice-cold ACSF and three times in ice-cold ACSF supplemented with 100
mMglycine. Residual reactive biotinwas quenched by incubating twice in
ice-cold ACSF supplemented with glycine, 20 min, 4°C, with bubbling
95%O2/5%CO2. And slices were washed four times with ice-cold ACSF.
Tissue was lysed by triturating in RIPA buffer several times through a
P200 pipette tip and rotating 30 min, 4°C. Cellular debris was cleared by
centrifugation at 18,000  g, 20 min, 4°C and protein concentrations
were determined using the BCAprotein assay. Biotinylated proteins were
isolated and analyzed as described for cells lines, above. A bead:lysate
ratio of 40 l streptavidin agarose:20 g striatal lysate was empirically
determined optimal to quantitatively recover all biotinylated DAT.
TIRF colocalization studies. SK-N-MC cells stably expressing TagRFP-
T-DAT were treated with the indicated drugs for the indicated times,
37°C and were rapidly chilled by washing three times in ice-cold PBS.
Cells were incubated with 0.2 g/ml Alexa488-cholera toxin subunit B
(CTX), 45 min, 4°C, washed three times in PBS and fixed in 4% parafor-
maldehyde, 10 min, at room temperature. Total internal reflection fluo-
rescence (TIRF) images in the red and green channels were captured
using the TESM microscope (Bioimaging Group, University of Massa-
chusetts Medical School) as described by Navaroli et al., (2012). Briefly,
images of through-the-lens TIRF were generated using 491 nm
(Alexa488-CTX) and 561 nm (TagRFP-T-DAT) laser illumination to-
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gether with a 1.49 NA objective lens (Olym-
pus). Stack of optical sections were acquired at
100 nm z-spacing. CTX and DAT TIRF images
were analyzed together to determine the frac-
tion of DAT fluorescence that was associated
with CTX-positive fluorescence. DAT and
CTX 3-D image stacks were imported into FiJi
(ImageJ), the best DAT focal plane was deter-
mined, and both DAT and CTX planes were
extracted from that stack. If there was more
than one expressing cell in the DAT image, the
DAT and CTX image pairs were cropped to
produce separate image pairs for each cell.
Next, the DAT image was used to segment cell
from background by first smoothing to reduce
noise, then applying a visually determined,
global intensity threshold, and creating a bi-
nary version of the DAT image. The original
DAT and CTX images were multiplied by the
binary DAT image to eliminate background
from the analysis. Finally, the averageDAT and
CTX dark current intensities for the corre-
sponding images were subtracted from the re-
maining pixels. Next, CTX images were
analyzed to identify CTX-positive pixels using
custom software. Contrast-to-noise CTX sig-
nals were not always sufficient to apply simple
global intensity thresholds, thus we developed
an approach to calculate for each pixel a likeli-
hood (ranging from 0 to 1) that a pixel was
CTX-positive. We modeled the gray level (in-
tensity) histogram, GLH(i), of the CTX image
as a simple linear sum of the CTX-negative
(ctx) and CTX-positive (ctx) histograms:
GLHi  GLHctxi  GLHctxi,
(1)
where the distribution of each species is a
Gaussian:
GLHctxi  Actx  exp  i  ictx22  k  2 ; k  1, (2)
and
GLHctxi  Actx
 exp i  ictx2
2  k 2
; k  ictx
ictx
. (3)
A, i, and k  2are the amplitude, mean
(ictx  ictx) and variance of each distribution, with the variance
proportional to themean. TheGLH of the CTX imagewas calculated and
fit with Equation 1 using the
Levenberg–Marquardt nonlinear curve-fitting algorithm of the Grace
plotting package (http://plasma-gate.weizmann.ac.il/Grace/). The equa-
tion fit theGLHwell in all cases, with r 2 0.959 0.0031 (mean SEM,
n  123 cells). The probability P of a pixel of intensity i being CTX-





for all cell (nonbackground) pixels. The percentage of DAT associated
with CTX-positive pixels was calculated as follows:
DATctx  100
x y 	DATx, y  PctxCTXx, y

x y DATx, y
, (5)
where DAT(x, y) and CTX(x, y) are the DAT and CTX fluorescence
intensities at pixel (x, y). The percentage DATctx was determined for
each cell analyzed and the mean SEM of all cells calculated.
Internalization assay.RelativeDAT initial internalization rates
were measured in DAT-SK-N-MC cells by reversible biotinyla-
tion as previously described (Loder and Melikian, 2003; Holton
et al., 2005; Boudanova et al., 2008b). Cells plated in 6-well plates
were pretreated  the indicated drugs, 20 min, 37°C and were
rapidly chilled by washing three times with PBS2. Surface pro-
teins were biotinylated twice for 15 min, 4°C with 2.5 mg/ml
NHS-SS-biotin and were quenched twice, 15 min, 4°C with
PBS2/100mM glycine. One set of cells were kept at 4°C andwere
used to determine DAT surface levels at t  0 and stripping
efficiency. Cells were rapidly warmed to 37°C by washing three
times in prewarmed PBS2/g/BSA containing the indicated
drugs and incubated in the same solutions for 10 min, 37°C,
followed by rapidly cooling to 4°C to stop internalization. Resid-
ual surface biotin on internalization samples and stripping con-
trols (cells that remained at 4°C) was removed by reducing twice
for 15 min, 4°C with 100 mM Tris(2-carboxyethyl)phosphine
(TCEP). Cells were lysed and biotinylated proteins were isolated
with streptavidin agarose and analyzed by SDS-PAGE and immu-
noblotting for DAT as described above for steady state biotinyla-
tion. Internalization rates were calculated as the % DAT
internalized over 10minutes as compared to total surface protein
labeled at time  0. Assays were only included if stripping effi-
ciencies were 90%.
Figure 1. Dynamin inhibitors reduce DAT activity and surface levels, but do not inhibit PKC-stimulated DAT downregulation in PC12
cells.A, [ 3H]DAuptake assay. DAT-PC12 cellswere pretreated80Mdynasore, 30min, 37°C, followedby treatment1MPMA, 30
min, 37°C, andDAuptakewasmeasuredwith 1MDA, as described inMaterials andMethods. Data are expressed as percentage specific
DAuptakeSEM.Asterisks indicatesignificantlydifferent fromvehiclepretreatment,*p0.05,***p0.0001;# indicatessignificantly
different from dynole pretreatment, p 0.05, one-way ANOVA with Bonferroni’s multiple-comparison test; n 6–9. B, [ 3H]Alanine
uptake assay. DAT-PC12 cells were treated80 M dynasore, 60 min, 37°C and Na-dependent alanine uptake was measured as
described inMaterials andMethods. Average data are presentedSEM (n 2). C,D, Surface biotinylation studies. DAT-PC12 cellswere
pretreated with or without the indicated dynamin inhibitors, 30 min, 37°C, followed by treatment1M PMA, 30 min, 37°C. Surface
proteins were biotinylated and biotinylated proteins were isolated as described inMaterials andMethods. C, Representative DAT immu-
noblot showing surface and 1⁄4 total protein.D, AveragedDAT surface levels expressedaspercentage total DATSEM.Asterisks indicate
significantly different from vehicle-treated cells, **p 0.01, ***p 0.001, ****p 0.0001; # indicates significantly different from
pretreatment control, p 0.05, one-wayANOVAwith Bonferroni’smultiple-comparison test;n 3–4.
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Results
If dynamin is required for basal DAT internalization we would
expect that acutely inhibiting dynamin would either increase
DAT function and surface levels, by blocking endocytosis and
continuing to insert DAT into the plasma membrane, or
would have no net effect on DAT surface levels by blocking
both DAT endocytosis and recycling. Likewise, if dynamin
were required for PKC-stimulated DAT internalization we
would expect dynamin inhibition to attenuate PKC-stimu-
lated DAT downregulation and surface loss. We first blocked
dynamin function with dynasore, a noncompetitive dynamin
GTPase inhibitor (Macia et al., 2006; Kirchhausen et al.,
2008), and tested its effects on [ 3H]DA uptake in DAT-PC12
cells. PKC activation with 1 M PMA, 30 min, 37°C signifi-
cantly decreased DA uptake to 33.2  3.2% control levels. Sur-
prisingly, 80 M dynasore treatment, 30 min, 37°C significantly
decreasedDAT activity to 62.7 7.7% control levels (Fig. 1; n 9).
Following pretreatment with 80 M dynasore, 30 min, 37°C PKC
activation furtherdecreasedDAuptake to23.03.5%vehicle levels,
which was significantly less than dynasore treatment alone (p 
0.05; Fig. 1A).Dynasore effects onDAuptakewere not due to global
perturbations in the transmembrane sodium gradient, as Na-
dependent alanine transport was not significantly reduced by dyna-
sore treatment (p 0.33; Fig. 1B).
Dynasore-mediated DAT functional loss could be due to di-
rect effects on transporter function or DAT depletion from the
plasmamembrane. To distinguish between these two possibilities
we used surface biotinylation to measure DAT surface levels fol-
lowing dynasore treatment. Treatment with 80M dynasore, 30
min, 37°C significantly reduced DAT sur-
face levels to 55.9  9.2%control levels
(Fig. 1C), demonstrating that DAT func-
tional loss following dynasore treatment
was due to DAT surface depletion. Treat-
ment with 1 M PMA, 30 min, 37°C de-
creased DAT surface levels to 40.2 4.2%
control levels, and dynasore pretreatment
did not significantly inhibit further PMA-
stimulated DAT surface loss (Fig. 1C),
suggesting that PKC-stimulatedDAT inter-
nalization is dynamin-independent inPC12
cells.Wefurther testedwhetherachemically
unrelated dynamin inhibitor, dynole 34-2,
would similarly affect DAT surface levels.
Dynole is anuncompetitive dynamin inhib-
itorwithhigherpotency thandynasore (Hill
et al., 2009). In control experiments, 10 M
dynole completely blocked TfR endocytosis
in control loading experiments using Tf-
Alexa594 (data not shown). Pretreatment
with 10 M dynole, 30 min, 37°C signifi-
cantly decreased DAT surface levels to
62.7  5.5% control levels (Fig. 1C), and
similar to dynasore, did not significantly in-
hibit further PMA-stimulated DAT surface
loss.These results suggest that, inPC12cells,
both constitutive andPKC-stimulatedDAT
internalization are dynamin-independent.
Moreover, constitutive DAT surface loss
during dynamin inhibition strongly sug-
gests that DAT endocytic recycling requires
dynamin.
To test whether DAT surface loss in
response to dynamin inhibition was dependent on cellular con-
text, we also tested the effect of dynamin inhibitors onDAT stably
expressed in the dopaminergic neuroblastoma cell line SK-N-MC
(DAT-SK-N-MC cells). Similar to results observed inDAT-PC12
cells, 10 M dynole treatment, 30 min, 37°C significantly de-
creasedDAT surface levels to 68.0 6.8% control levels, whereas
the inactive analog, dynole 31-2, had no significant effect onDAT
surface levels (97.6  8.4% control; Fig. 2A). We next tested
whether DAT undergoes PKC-mediated surface loss following
dynole pretreatment. DAT-SK-N-MC cells were pretreated10
M dynole, 30 min, 37°C followed by PKC activation with 1 M
PMA, 30 min, 37°C. Following vehicle pretreatment, PKC acti-
vation significantly decreased DAT surface levels to 78.6 6.0%
control levels (Fig. 2A). In contrast, we observed no additional
DAT surface loss in response to PKC activation following pre-
treatment with 10 M dynole, 30 min, 37°C (Fig. 2A). Moreover,
total DAT levels were not significantly changed over the experi-
mental time course following either dynole (119.6 7.9%control
levels) or PMA (115.4  13.6% control levels) treatments (data
not shown). To assure that dynole effects on DAT surface levels
were not due to off-target effects, we also testedwhether dynamin
inhibition with dynasore affected DAT surface levels. Similar to
our results with dynole, 80M dynasore treatment, 30 min, 37°C
significantly decreased surface DAT to 77.0 5.6%control levels
(Fig. 2B).
Together with our PC12 cell data, our results suggested that
constitutive DAT endocytosis is dynamin-independent and that
dynamin inhibition either accelerates DAT endocytosis or blocks
endocytic recycling, resulting in net DAT surface depletion.
Figure 2. Dynamin inhibitors reduce DAT surface levels and inhibit PKC-stimulated DAT surface loss in SK-N-MC cells. Surface
biotinylation studies. DAT-SK-N-MC cells were pretreated with or without the indicated dynamin inhibitors (or inactive analog,
dynole 31-2), 30min, 37°C, followedby treatment1MPMA, 30min, 37°C. Surface proteinswere biotinylated andbiotinylated
proteins were isolated as described in Materials and Methods. A, Dynamin inhibition with dynole 34-1. Left, Representative DAT
immunoblot showing surface and 1/3 total DAT. Right, Average data expressed as percentage vehicle DAT surface levels SEM.
Asterisks indicate significantly different from vehicle control, one-way ANOVA with Bonferroni’s multiple-comparison test, *p
0.05, **p  0.01; n  8. B, Dynamin inhibition with dynasore (80 M) or the inactive dynole analog 31-2 (10 M). Left,
Representative DAT immunoblot showing surface and 1/3 total DAT. Right, Average data expressed as percentage vehicle DAT
surface levelsSEM. *Significantly different fromvehicle control, one-wayANOVAwithDunnett’smultiple-comparison test,p
0.05; n 8.
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However, PKC-stimulated DAT surface
loss was unaffected by dynamin inhibition
in PC12 cells, whereas it was completely
blocked in SK-N-MC cells. This promp-
ted us to ask whether dynamin inhibitors
similarly affected DAT surface levels in
native dopaminergic neurons. To address
this question, we performed ex vivo sur-
face biotinylation studies in acute mouse
striatal slices to test the effect of dynamin
inhibition on DAT surface stability and
PKC-stimulated internalization in intact
adult dopaminergic terminals. In slices
pretreated with vehicle, PKC activation
with 1 M PMA, 30 min, 37°C signifi-
cantly decreased DAT surface levels to
77.3  3.6% control levels (Fig. 3A).
Treatment with 10 M dynole, 30 min,
37°C likewise significantly decreasedDAT
surface levels to 80.7 4.6% control lev-
els, and dynole pretreatment completely
abolished further PKC-stimulated DAT
surface loss. To assure that the biotinyla-
tion reagent did not permeate dopamine
neurons, immunoblots were probed in
parallel for tyrosine hydroxylase. Cellular
integrity was not compromised during
this protocol, as we routinely observed
1% tyrosine hydroxylase biotinylation
(Fig. 3B). Total DAT protein levels were
unaffected by dynole or PMA treatments
(PMA: 100.4  4.3% control levels; dyn-
ole: 104.4 5.3% control levels, n 12),
suggesting that internalized DAT is not
targeted to degradation in adult dopaminergic terminals. These
results are consistent with those obtained in SK-N-MC cells, fur-
ther supporting that dopaminergic SK-N-MC cells closely reflect
neuronal DAT trafficking mechanisms.
Dynamin inhibition in SK-N-MC cells and striatal slices de-
pleted surface DAT, suggesting that dynamin is not required for
basal DAT internalization, and is likely required for DAT recy-
cling back to the cell surface. Further, we observed no additional
DAT surface loss in response to PKC activation following
pretreatmentwithdynamin inhibitors.Thereare twopossible inter-
pretations of this result: (1) that PKC-stimulated DAT internaliza-
tion is dynamin-dependent, or (2) that there is a finite DAT
surface pool in SK-N-MC cells and adult dopaminergic neurons
that is endocytic-willing, and that dynole treatment depleted this
DATpool from the cell surface. Thus, the remainingDAT surface
pool would be endocytic-resistant and therefore unable to inter-
nalize following PKC activation, regardless of whether or not
dynamin was required. If this were the case, our ability to test
dynamin dependence under these experimental conditions
would be limited. To distinguish between these two mechanistic
possibilities, we used two independent approaches to blocking
endocytic recycling and deplete the putative “endocytic-willing”
DAT surface population in DAT-SK-N-MC cells: (1) monensin
treatment, which blocks the vacuolar H ATPase and has been
shown to reduceDAT surface levels (Sorkina et al., 2009), and (2)
18°C temperature blockade, which was previously demonstrated
to block DAT endocytic recycling (Loder and Melikian, 2003;
Sorkina et al., 2009). We reasoned that if all surface DAT were
endocytic-willing, we would observe continual DAT surface loss
Figure 3. Dynamin inhibition reduces DAT surface levels and inhibits PKC-stimulated DAT surface loss in adult dopami-
nergic neurons. Ex vivo striatal slice biotinylation studies. Coronal slices were prepared from mouse striatum as described
in Materials and Methods. Slices were pretreated10M dynole, 30 min, 37°C, were subsequently treated1M PMA,
30 min, 37°C, and surface proteins were biotinylated and isolated as described in Materials and Methods. A, DAT biotiny-
lation. Left, Representative DAT immunoblots showing surface and total DAT in equivalent amounts of tissue lysate. Right,
Average data expressed as percentage vehicle DAT surface levels  SEM. *Significantly different from vehicle control,
one-way ANOVA with Bonferroni’s multiple-comparison test, p 0.01, n 12. B, TH biotinylation. Left, Representative
TH immunoblots showing biotinylated and total TH in equivalent amounts of tissue lysate. Right, Average data percentage
total TH biotinylated SEM, n 12.
Figure 4. DAT surface loss plateaus over time during recycling blockade. Cell surface
biotinylation studies; DAT-SK-N-MC cells were either treated with 10M monensin, 37°C
(A) or incubated at 18°C (B) for the indicated times and surface DAT levels were measured
by biotinylation as described in Materials and Methods. Average data are presented as
percentage DAT surface levels at t 0, n 4 – 6.
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over time, whereas if there were an endocytic-resistant pool we
would expect an initial surface loss that plateaus over time. Treat-
ment with 25 M monensin, 37°C resulted in a gradual DAT
surface depletion that plateaued by 60min (Fig. 4A). Likewise, an
18°C recycling blockade resulted in gradual decreases in surface
DAT that plateaued after 30 min (Fig. 4B). Together, these data
are consistent with the hypothesis that DAT distributes into, at
minimum, two distinct surface pools: one that is endocytic-
willing and another that is endocytic-resistant for constitutive
internalization. Interestingly, we only observed a trafficking re-
sistant DAT pool in striatal slices and SK-N-MC cells, but not in
PC12 cells (Fig. 1), suggesting that cellular context may strongly
influence DAT’s endocytic capacity and that SK-N-MC cells
more closely reflect native DAT trafficking potential.
We next asked whether the remaining DAT surface pool, that
was endocytic-resistant to constitutive internalization, was capa-
ble of PKC-stimulated internalization. DAT-SK-N-MC cells
were preincubated at 18°C to deplete the endocytic-willing DAT
surface population, followed by PKC activation with 1 M PMA,
45 min, 18°C. In cells preincubated at 37°C, PKC activation re-
ducedDAT surface levels to 70.9 4.3% vehicle levels (Fig. 5). In
contrast, when the endocytic-willing DAT surface pool was de-
pleted at 18°C, 45minwe observed no furtherDAT surface loss in
response to PKC activation (98.3 9.4% control levels, p 0.45,
n 8–15), consistent with a trafficking-resistant DAT surface
population. The lack of PKC-stimulatedDAT surface loss at 18°C
was not due to inability of PMA to activate PKC at 18°C, as PMA
treatment at 18°C was capable of significantly decreases DAT
surface expression in PC12 cells (data not shown), which do not
express a endocytic-resistant DAT surface pool. Thus, the inabil-
ity of DAT to internalize in response to PKC activation following
an 18°C surface depletion that we observed in SK-N-MCcells was
likely due to a loss of the endocytic-willing DAT surface pool.
We next tested whether the endocytic-resistant DAT surface
pool was present in adult dopaminergic neurons by asking (1)
whether monensin would deplete surface DAT in acute mouse
striatal slices and (2) whether the residual DAT surface pool was
responsive to PKC activation. The results are shown in Figure 6.
Identical to our results in DAT-SK-N-MC cells, monensin pre-
treatment significantly decreased DAT surface levels to 72.0 
5.7% vehicle-pretreated cells (p 0.004, Student’s t test, n 21).
PKCactivation significantly reducedDAT surface levels to 73.3
3.3 percent vehicle levels, and monensin pretreatment completely
blocked further PKC-stimulated reduction
in DAT surface expression (Student’s t test,
p0.40), consistentwith thepresenceof an
endocytic-resistant DAT surface pool in
adult striatal dopaminergic neurons. Nei-
ther monensin nor PMA treatments de-
creased total DAT protein levels (data not
shown). We did note, however, that mo-
nensin slightly increased cell permeability to
the biotinylation reagent, permitting 8%
of TH to be biotinylated in the monensin-
treated slices (Fig. 6B). Together with our
results in SK-N-MC cells, these results sug-
gest that DAT is distributed between
endocytic-willing and -resistant surface
pools.
We next investigated the possible
physical basis for the endocytic-willing
and -resistant DAT surface pools. Previ-
ous studies reported that DAT partitions
between lipid raft and nonraft plasma membrane microdomains
(Adkins et al., 2007; Foster et al., 2008; Cremona et al., 2011;
Navaroli et al., 2011), and that flotillin-1 retainsDAT in lipid rafts
(Cremona et al., 2011; Sorkina et al., 2013) and is required for
PKC-stimulatedDAT endocytosis (Cremona et al., 2011) inHEK
cells. Thus, we asked whether the endocytic-willing DAT surface
pool preferentially arises from either raft or nonraft loci in SK-
N-MCcells. To address this possibility, we usedTIRFmicroscopy
to quantify TagRFP-T-DAT surface colocalization with
Alexa488-CTX following treatment 10 M dynole, 30 min,
37°C. TagRFP is a monomeric RFP that is3-fold brighter than
mCherry (Shaner et al., 2004), and control experiments con-
firmed that TagRFP-T-DAT expresses, functions and is subject to
PKC-mediated downregulation comparable to wild-type DAT
(data not shown). If the endocytic-willing DAT pool preferen-
tially internalizes from either membrane rafts or nonrafts, we
would expect to detect either a decrease or increase in the per-
centage surface TagRFP-T-DAT localized toCTX-positive pixels,
respectively. Alternatively, if DAT internalizes equivalently from
rafts and nonrafts, we would expect no shift in the overall per-
centage surface TagRFP-T-DAT localized toCTX-positive pixels.
The ensemble dataset is shown in Figure 7. In vehicle-treated
cells, 67.7  2.4% surface TagRFP-T-DAT colocalized in CTX-
positive pixels. Following treatment with 10 M dynole, 30 min,
37°C, TagRFP-T-DAT distribution in CTX-positive pixels was
not significantly different from vehicle-treated cells (65.6 2.2%
surface DAT), suggesting that the endocytic-willing population
internalized equivalently from membrane raft and nonraft mi-
crodomains. To assure that preferential raft internalization was
detectable in our system, we also measured the TagRFP-T-DAT
surface distribution following PKC activationwith 1MPMA, 30
min, 37°C. Following PKC activation TagRFP-T-DAT colocal-
ization in CTX-positive pixels significantly decreased to 58.5 
3.6% surface DAT (p  0.05, one-way ANOVA with Dunnett’s
multiple-comparison test). These data suggest that raft-specific
loss is detectable in our system and are consistent with previous
results demonstrating that PKC-stimulated decreases in DAT
surface expression occur primarily from membrane raft mi-
crodomains (Cremona et al., 2011).
Dynamin inhibition for 60 min completely depleted the
endocytic-willing DAT surface pool in both striatal slices and
SK-N-MC cells. Therefore, it was not possible to interpret
whether lack of PKC-stimulated DAT internalization following
Figure 5. Recycling blockade reveals a DAT surface pool resistant to PKC-stimulated endocytosis. Cell surface biotinylation
studies; DAT-SK-N-MC cells were preincubated for 45 min at either 37°C or 18°C, followed by treatment with 1M PMA, 30 min,
37°C or 18°C, respectively. DAT levels were subsequently measured by biotinylation as described in Materials and Methods. Left,
Representative DAT immunoblot showing surface and 1/3 total DAT in lysate after treatmentwith the indicated conditions. Right,
Averaged data expressed as percentage pretreatment condition. *Significantly less than control, Student’s t test; p 0.03, n
6–12.
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dynole treatment was due actual dynamin
dependence, or an a priori inability of the
remaining DAT surface population to in-
ternalize regardless of whether or not
dynamin was active. Moreover, dynole/
dynasore-mediated DAT surface deple-
tion could be due to enhanced interna-
lization or reduced endocytic recycling.
To directly test whether dynamin was re-
quired for constitutive and PKC-stimu-
lated DAT endocytosis, we used reverse
biotinylation tomeasure the effect of dyn-
ole on basal and PKC-stimulated DAT in-
ternalization rates in SK-N-MC cells. The
advantage of this approach is that we can
measure DAT internalization rates di-
rectly, before depleting the endocytic-
willing DAT surface pool. For these
experiments, we pretreated cells 10 M
dynole for 20min, 37°C, before biotinyla-
tion. This pretreatment did not com-
pletely deplete the endocytic-willing DAT
surface pool, as determined in a dynole
time course, but allowed sufficient time
for dynole to inhibit dynamin, as deter-
mined in Tf loading assays (data not
shown). Following vehicle pretreatment,
DAT robustly internalized and PKC acti-
vation significantly increased DAT inter-
nalization rates to 179  20.5% control
levels (Fig. 8). Dynole preincubation did
not significantly inhibit constitutive DAT internalization rates.
However, dynole completely blocked PKC-enhanced DAT inter-
nalization rates (Fig. 8). Thus, DAT surface loss in response to
dynamin inhibition is not due to accelerated constitutive DAT
endocytosis, and is likely caused by blocked endocytic recy-
cling back to the plasma membrane. Moreover, these results
demonstrate that regulated DAT endocytosis is differentially
dependent upon dynamin: constitutive DAT internalization is
dynamin-independent, whereas PKC-stimulated DAT inter-
nalization is dynamin-dependent.
Mounting evidence indicates that, in addition to its obligate
role in clathrin-mediated endocytosis, dynamin directly interacts
with the actin cytoskeleton and is required for cortical actin cy-
toskeleton dynamics. Moreover, actin/dynamin interactions are
reported to play a central role in recycling via the bulk endocytic
route. We postulated that dynamin might be required for DAT
endocytic recycling via its interactions with the actin cytoskeleton.
To test this possibility, we used cytochalasin D (CytoD) to disrupt
the actin filaments in striatal slices and tested whether actin was also
required for dynamin-dependent DAT surface stability. Slices were
pretreated with either vehicle or 0.2 g/ml CytoD, 30 min, 37°C,
followed by treatment either with vehicle or 10 M dynole, 30 min,
37°C. The results are shown in Figure 9. CytoD treatment alone
significantly reduced DAT surface levels to 69.9  5.1% control
levels. Dynole treatment significantly reduced DAT surface levels to
67.2  5.0% control levels and CytoD pretreatment completely
blocked further dynole-mediated DAT surface loss. CytoD had no
effect on slice permeability to the biotinylation reagent, as deter-
mined in immunoblots probed for TH in parallel (data not shown).
CytoD treatment did not target DAT to a degradative fate, as total
DAT protein levels were unchanged over the course of the experi-
ment (91.7 10.1% control levels).Moreover, CytoDdid not glob-
ally disrupt endocytic trafficking, as TfR surface levels were not
significantly altered by CytoD treatment (118 12.6% control; Fig.
9B). Together, with our dynamin results, these data suggest that
dynamin activity controlsDATendocytic recycling in amanner that
engageswith the actin cytoskeleton, but that constitutiveDAT inter-
nalization is both dynamin- and actin-independent.
Discussion
Previous studies using siRNAor dominant-negativemutants report
that constitutive, PKC-stimulated and AMPH-stimulated DAT in-
ternalization are dynamin-dependent (Daniels and Amara, 1999;
Saunders et al., 2000; Sorkina et al., 2005; Eriksen et al., 2009).How-
ever, several lines of evidence support that nonclassical endocytic
Figure 6. Recycling blockade reveals an endocytic-resistant DAT surface population in adult dopaminergic neurons. Ex vivo
striatal slice biotinylation studies. Coronal sliceswere prepared frommouse striatum as described inMaterials andMethods. Slices
were pretreated25M monensin, 60 min, 37°C and were subsequently treated1M PMA, 30 min, 37°C. Surface proteins
were biotinylated and isolated as described inMaterials andMethods.A, DAT biotinylation. Left, RepresentativeDAT immunoblots
showing surface and total DAT in equivalent amounts of tissue lysate. Right, Average DAT surface levels expressed as percentage
pretreatment control SEM. *Significantly different from control, Student’s t test, p 0.005, n 21. B, TH biotinylation. Left,
Representative TH immunoblots showing biotinylated and total TH in equivalent amounts of tissue lysate. Right, Average data
percentage total TH biotinylated SEM; n 21.
Figure 7. The endocytic-willing DAT surface population arises independent of membrane
raft microdomains. TIRF microscopy studies; SK-N-MC cells stably expressing Tag-RFP-T-DAT
were treated10M dynole or 1M PMA, 30 min, 37°C, were labeled with Alexa488 CTX-B,
4°C, fixed, and surface signals were imaged via TIRF microscopy as described in Materials and
Methods. The percentage total surface DAT localized to CTX-positive was determined as de-
scribed. Graph depicts DAT/CTX colocalization for all cells imaged (n 40, vehicle; 42, dynole;
38, PMA).
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mechanisms facilitate constitutive and PKC-stimulated DAT endo-
cytosis. DAT relies on a noncanonical carboxy terminal endocytic
signal (Miranda et al., 2004; Holton et al., 2005) and an endocytic
brake tempers constitutiveDAT internalization rates (Boudanova et
al., 2008b; Sorkina et al., 2009). PKC-stimulated DAT internaliza-
tion requires theneuronalGTPase,Rin (Navaroli et al., 2011),which
has not previously been implicated in either clathrin- or dynamin-
dependent endocytosis. Moreover, the lipid raft protein, flotillin-1,
retains DAT in membrane raft microdomains and is required for
PKC-stimulated DAT internalization (Cre-
mona et al., 2011). It should be noted that a
recent study indicated that although
flotillin-1 retains DAT in lipid microdo-
mains, it is not required forPKC-stimulated
DAT internalization (Sorkina et al., 2013).
Why have such disparate mechanisms been
observed forconstitutiveandPKC-stimulated
DAT endocytosis? To date, DAT trafficking
studies have been performed primarily in
non-neuronal cell lines or cultured midbrain
neurons derived from P0–P2 rodents, which
may not faithfully recapitulate endocytic
mechanisms inherent in adult dopaminergic
neurons. Studies comparingDAT surface dy-
namics inHEKversusNeuro2Acells similarly
found striking differences inDAT lateralmo-
bility between the two cell types (Adkins et al.,
2007). Indeed, our current results comparing
PC12 cells, SK-N-MC cells and striatal slices
clearly demonstrate that DAT’s dynamin de-
pendence is highly sensitive to cellular context
(Figs.1–3).Interestingly,SK-N-MCcellsiden-
tically recapitulated striatal slice results, sug-
gesting that SK-N-MC neuroblastoma is a
reliable culture model for constitutive and
PKC-stimulated DAT internalization studies.
Interestingly, constitutive and PKC-stimula-
tedDATendocyticratesaremarkedlylargerin
PC12cells (LoderandMelikian,2003) than in
either SK-N-MCcells or striatal slices (Figs. 2,
3, 8). Because PC12 cells lack an endocytic-
resistant DAT surface pool, it is possible that
mechanisms limitingDAT’s endocytic capac-
ity in SK-N-MC cells and striatal dopaminer-
gic terminals may also dampen DAT
endocytic rates. In addition to contextual dif-
ferences, many studies used siRNA and
dominant-negative expression approaches
that chronically inhibit dynamin over days.
Because dynamin is required for multiple
membrane fission events, including exit from
the trans-Golgi network, it is possible that
dynamin-independentmechanismswere sec-
ondarily perturbed.
Numerous studies in cell lines deter-
mined that PKC enhancesDAT internaliza-
tion (Melikian andBuckley, 1999;Granas et
al., 2003; Miranda et al., 2005, 2007; Boud-
anova et al., 2008b; Foster et al., 2008; Na-
varoli et al., 2011; Sakrikar et al., 2012;
Sorkina et al., 2013). However, several in-
vestigations in cultured dopaminergic neu-
rons indicate that PKC activation does not
induce DAT sequestration (Sorkina et al., 2006; Eriksen et al., 2009;
Rao et al., 2011, 2012), questioning the physiological relevance of
PKC-stimulated DAT internalization. Consistent with a recent
report (Cremona et al., 2011), we readily detected PKC-induced
DAT sequestration in striatal slices (Fig. 3), demonstrating that na-
tive DAT internalizes in response to PKC activation in mature do-
paminergic terminals. Unlike cultured cells, intact striatal slices
retain multiple regional synaptic connections. Thus, because PKC
was activated across the entire slice, it is possible that PKCactivation
Figure 8. Constitutive DAT internalization is dynamin-independent, whereas PKC-stimulated DAT internalization is dynamin-
dependent.DAT internalizationassays;DAT-SK-N-MCcellswerepretreated10Mdynole, 20min, 37°C, andDAT internalization
rates were measured by reversible biotinylation10 M dynole,1 M PMA, 10 min, 37°C as described in Materials and
Methods. Left, Representative DAT immunoblots. For each pretreatment condition (vehicle, top; 10 M dynole, bottom), blots
showtotal surfaceDATat t0 (total), strip control (strip), andamountofDAT internalized in thepresenceof vehicle orPMA.Right,
Averaged data, expressed as percentage vehicle-treated cells SEM. *Significantly different from vehicle, one-way ANOVAwith
Bonferroni’s multiple-comparison test; p 0.05, n 4.
Figure 9. Dynaminmediates DAT recycling via an actin-dependent mechanism in adult dopaminergic neurons. Ex vivo striatal
slice biotinylation studies. Coronal slices were prepared frommouse striatum as described in Materials and Methods. Slices were
pretreated0.2 g/ml cytochalasin D, 30 min, 37°C, and were subsequently treated10 M dynole, 30 min, 37°C. Surface
proteins were biotinylated and isolated as described in Materials and Methods. A, DAT biotinylation. Left, Representative DAT
immunoblots showing surface and total DAT in equivalent amounts of tissue lysate. Right, AverageDAT surface levels expressed as
percentage vehicle-treated DAT levels SEM. Asterisks indicate significantly different from vehicle, one-way ANOVA with Bon-
ferroni’s multiple-comparison test; *p  0.05, **p  0.01, n  7. B, Effect of CytoD on DAT and TfR surface levels. Left,
Representative immunoblots showing biotinylated and total DAT (top) and TfR (bottom) in equivalent amounts of tissue lysate
following treatment0.2g/mlCytoD.Right, Averagedataexpressedaspercentagevehicle surface levelsSEM.*Significantly
different from vehicle control, Student’s t test; p 0.02, n 6.
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in afferents synapsing onto the dopaminergic terminals could have
contributed to DAT surface loss. For example, Group I mGluR-
mediated PKC activation stimulates DAT-mediated DA release in
substantia nigra slices (Opazo et al., 2010) that, in turn, could have
drivenDAT surface loss via well described substrate-mediatedDAT
internalization (Saunders et al., 2000; Zahniser and Sorkin, 2004;
Boudanova et al., 2008a; Hong and Amara, 2013).
Studies investigating DAT’s intracellular fate following inter-
nalization have yielded varying results. When bound to extracel-
lular antibody or fluorescent ligand, constitutively internalized
DAT targets to rab4 “short-loop” endosomes, late endosomes,
and lysosomes (Eriksen et al., 2010). In contrast, biochemical
studies examining unlabeled or biotinylated DAT demonstrate
that DAT robustly recycles to the plasma membrane (Loder and
Melikian, 2003; Boudanova et al., 2008a; Chen et al., 2013), tar-
gets to TfR- and rab11-positive recycling endosomes in neuronal
cell lines and synaptosomes (Melikian and Buckley, 1999;
Sorkina et al., 2003; Furman et al., 2009) and that rab11 activity
regulates DAT surface expression (Furman et al., 2009). More-
over, striatal fractionation demonstrated that DAT is enriched in
TfR-positive, but not late endosomal (rab7-positive), organelles,
both under basal and PKC-activated conditions (Rao et al.,
2011). Total DAT levels were unchanged in both SK-N-MC cells
(Fig. 2) and striatal slices (Fig. 3) following 30 min PKC activa-
tion, suggesting that DAT does not degrade following internal-
ization, consistent with our previous findings in PC12 cells
(Loder and Melikian, 2003; Holton et al., 2005). Recent studies
demonstrated that TfR, rabies G glycoprotein, and -amyloid
anomalously target to degradation if internalized while bound to
antibody (Tampellini et al., 2007; St Pierre et al., 2011), suggesting
that antibody/DAT complexes may anomalously target to degrada-
tion.Additionally, given thatPKC-stimulatedDATendocyticmech-
anisms are quite sensitive to cellular context (Figs. 1–3), it is possible
that results from either non-neuronal cell lines or primary dopami-
nergicneuronsmaynot reflectPKC-stimulatedDATinternalization
in adult neurons. Finally, reported DAT degradation occurs in in-
stances where PKC is chronically activated (1–2 h), which may not
reflect rapid kinase activation/inactivation inherent to normal neu-
ronal signaling.
We observed that DAT’s endocytic capacity functionally seg-
regates into “endocyticwilling” and “endocytic-resistant” surface
pools in SK-N-MC cells and striatal slices (Figs. 5, 6). Moreover,
both constitutive and PKC-stimulated DAT internalization em-
anate from the endocytic-willing pool. Although these pools are
functionally evident, we currently do not know the physical basis
for these DAT surface pools. Moreover, it is not clear whether
AMPH-stimulated DAT internalization is also limited to this
pool, but future studies should be interesting in this regard. The
endocytic-resistant DAT pool could be absolutely fixed, andmay
have evolved to assure that dopaminergic terminals have a base-
line minimal DA clearance capacity. Alternatively, there may be
as yet unknown conditions that can recruit or limit DAT to and
from the endocytic-willing pool. Studies from Sankaranarayanan
and Ryan (2001) showed that intracellular calcium elevations
enhance synaptic vesicle endocytic capacities (Balaji et al., 2008).
Although synaptic vesicle endocytosis is markedly faster than
DAT internalization, these results suggest that neuronal endo-
cytic capacities are highly plastic and that DAT’s absolute endo-
cytic potential may be subject to change.
Previous fractionation studies indicated that DAT segregates
into membrane raft and nonraft membrane microdomains (Ad-
kins et al., 2007; Foster et al., 2008; Cremona et al., 2011). Our
TIRF studies revealed that constitutiveDAT internalization arises
equivalently from raft and nonraft domains (Fig. 7), suggesting
thatDAT’s absolute endocytic capacity is not dictated by lipid raft
localization. Because our TIRF studies were performed in fixed
cells using TagRFP-T-DAT, we cannot rule out the possibility
that DAT internalized preferentially from one microdomain and
was either replaced either by newly inserted DAT or via redistri-
bution from another microdomain before fixation. Future stud-
ies specifically examining DAT surface dynamics in real time
should shed further light on this possibility.
Although constitutive DAT internalization is dynamin-
independent and microdomain nonselective, PKC-stimulated
DAT endocytosis is dynamin-dependent (Fig. 8) and arises
strictly fromCTX-positive membrane rafts (Fig. 7). These results
are consistent with previous studies in which flotillin-1-mediated
DAT targeting to CTX-positive microdomains was required for
PKC-stimulated DAT internalization (Cremona et al., 2011).
Moreover, previouswork fromour laboratory demonstrated that
Rin GTPase interactions with DAT are required for PKC-
stimulated DAT internalization, and are enriched in lipid raft
microdomains (Navaroli et al., 2011). In contrast, fractionation
studies performed in LLC-PK1 cells revealed that PKC-
Figure 10. Model for constitutive and PKC-regulated DAT endocytic trafficking at dopaminergic terminals. Surface DAT distributes into endocytic-willing (30%) and endocytic resistant
(70%)pools, andalso into lipid raft andnonraftmembranemicrodomains. Both constitutiveandPKC-stimulatedDATendocytosis arise fromtheendocyticwilling surfacepool but aredifferentially
dependent upon dynamin: constitutive DAT internalization is dynamin-independent, whereas PKC-stimulated DAT internalization is dynamin-dependent. Membrane raft microdomains also play
distinct roles in DAT internalization– constitutive DAT internalization occurs equivalently from raft and nonraft domains, whereas PKC-stimulated DAT endocytosis emanates exclusively from
flotillin-rich lipid rafts microdomains. Once internalized, DAT endocytic recycling back to the plasma membrane critically relies upon dynamin working in concert with the actin cytoskeleton.
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stimulated DAT surface loss arises strictly from nonraft mem-
brane microdomains (Foster et al., 2008). These contrasting
resultsmay reflect detection of internalized raftmicrodomains by
fractionation, whereas TIRF imaging examines plasma mem-
brane directly. Alternatively, disparate findingsmay reflect inher-
ent differences between neuronal and non-neuronal cellular
backgrounds.
Our results demonstrate that constitutive DAT internaliza-
tion is dynamin-independent (Figs. 2, 3, 8), and suggest that a
dynamin- and actin-dependent mechanism controls DAT endo-
cytic recycling (Fig. 9). Recent studies indicate that dynamin di-
rectly links to the actin cytoskeleton via cortactin interactions,
and is required for Arp2/3 actin filament recruitment tomaintain
the cortical actin network (Schafer, 2004; Menon and Schafer,
2013). Moreover, receptors subject to sequence-dependent recy-
cling, such as the 2-adrenergic receptor, segregate to biochem-
ically distinct endosomal microdomains and require actin and
Arp2/3 for recycling (Puthenveedu et al., 2010). Thus, dynamin
may be integral to DAT recycling via its direct interaction with
the actin cytoskeleton.
Given our results, we propose a constitutive and PKC-
stimulated endocytic trafficking model for DAT, depicted in Fig-
ure 10. Currently, it is unclear whether recyclingDAT inserts into
endocytic-willing populations, or whether DAT can shift be-
tween endocytic-willing and -resistant pools postinsertion.
Moreover, it is not known whether DAT recycling is mediated by
sequence-dependent or bulk flow mechanisms. Future studies
directly examiningDAT surface dynamics and recycling determi-
nants should reveal the multimodal mechanisms dictating basal
and PKC-stimulated DAT endocytic trafficking.
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